Abstract
Among the extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli, 3.9% of K. pneumoniae showed nonsusceptibility to imipenem or meropenem; and their mechanism was the combination of ESBL and/or plasmid-mediated AmpC β-lactamase production and porin loss. The presence of bla CTX-M-14 and loss of OmpK36 were associated with higher carbapenem MICs.
Original language | English |
---|---|
Pages (from-to) | 87-89 |
Number of pages | 3 |
Journal | Diagnostic Microbiology and Infectious Disease |
Volume | 71 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2011 Sept |
Bibliographical note
Funding Information:We wish to thank all the contributing laboratories that provided isolates for this study. This work was supported by a research grant from the Korea Center for Disease Control (2009-E00520-00).
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases